Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Marata

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|October 21, 2014
Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trialsNicola Magrini, Giulio Formoso, Oreste Capelli, et al.
BMC Health Services Research|October 2, 2007
Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in ItalyNicola Magrini, Giulio Formoso, Anna Maria Marata, et al.
Recenti Progressi in Medicina|November 16, 2021
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]Claudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2020
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern ItalyCarlo Salvarani, Pamela Mancuso, Federica Gradellini, et al.
Annals of the Rheumatic Diseases|May 30, 2020
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based studyCarlo Salvarani, Gianluigi Bajocchi, Pamela Mancuso, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Anna Maria Marata, Walter Marrocco, Emanuela Arcangeli, et al.
Journal of Translational Medicine|October 22, 2021
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
Journal of Translational Medicine|October 22, 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
The European Respiratory Journal|April 1, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialCarlo Salvarani, Marco Massari, Massimo Costantini, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|October 21, 2014
Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trialsNicola Magrini, Giulio Formoso, Oreste Capelli, et al.
BMC Health Services Research|October 2, 2007
Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in ItalyNicola Magrini, Giulio Formoso, Anna Maria Marata, et al.
Recenti Progressi in Medicina|November 16, 2021
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]Claudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2020
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern ItalyCarlo Salvarani, Pamela Mancuso, Federica Gradellini, et al.
Annals of the Rheumatic Diseases|May 30, 2020
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based studyCarlo Salvarani, Gianluigi Bajocchi, Pamela Mancuso, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Anna Maria Marata, Walter Marrocco, Emanuela Arcangeli, et al.
Journal of Translational Medicine|October 22, 2021
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
Journal of Translational Medicine|October 22, 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
The European Respiratory Journal|April 1, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialCarlo Salvarani, Marco Massari, Massimo Costantini, et al.
Pageof 2